Oncology & Cancer

Strategy to reduce side effects in modern cancer therapy

An interdisciplinary team of researchers from the University of Vienna (Institute of Inorganic Chemistry) and the Medical University of Vienna (Institute for Cancer Research) has successfully developed a new strategy for ...

Oncology & Cancer

A protein that 'rebels' against breast cancer treatment

Despite the fact that the cure rate for breast cancer, the most common cancer in women, is very high (around 80%), this disease can nevertheless have very serious consequences. The majority of breast cancer-related deaths ...

Oncology & Cancer

Cell reprogramming to cure leukaemia and lymphoma

Researchers from the Centre for Genomic Regulation (CRG) in Barcelona reprogramme lymphoma and leukaemia cells to halt their malignancy. Resulting cells remain benign even when no longer subjected to treatment and reduce ...

Oncology & Cancer

Benefit of PET or PET/CT in recurrent bowel cancer is not proven

For patients in whom a recurrence of bowel cancer is suspected, the study data currently available allow no robust conclusions as to the advantages and disadvantages of using positron emission tomography (PET), alone or in ...

page 4 from 6